Modulation of endothelial cell network formation in vitro by molecular signaling of head and neck squamous cell carcinoma (HNSCC) exposed to cetuximab

Microvascular Research

Volumn 83, Issue 2, 2012, Pages 131-137

  Jouan Hureaux, Valérie ^a   Boura, Cédric ^a   Merlin, Jean Louis ^a,b   Faivre, Béatrice ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b Centre régional de lutte contre le cancer Alexis Vautrin CAV   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CD31 ANTIGEN; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; NOTCH4 RECEPTOR; PROTEOME; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EXPOSURE; ENDOTHELIUM CELL; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MODULATION; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, NOTCH; TONGUE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84856767217     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.07.008     Document Type: Article

References (40)

1. Al-Nedawi K., Meehan B., Kerbel R.S., Allison A.C., Rak J. Proc. Natl Acad. Sci. USA 2009, 106(10):3794-3799.
2. Amin D.N., Hida K., Bielenberg D.R., Klagsbrun M. Cancer Res. 2006, 66(4):2173-2180.
3. Ang K.K., Berkey B.A., Tu X., Zhang H.Z., Katz R., Hammond E.H., Fu K.K., Milas L. Cancer Res. 2002, 62(24):7350-7356.
4. Azemar M., Schmidt M., Arlt F., Kennel P., Brandt B., Papadimitriou A., Groner B., Wels W. Int. J. Cancer 2000, 86(2):269-275.
5. Baker C.H., Kedar D., McCarty M.F., Tsan R., Weber K.L., Bucana C.D., Fidler I.J. Am. J. Pathol. 2002, 161(3):929-938.
6. Bancroft C.C., Chen Z., Yeh J., Sunwoo J.B., Yeh N.T., Jackson S., Jackson C., Van Waes C. Int. J. Cancer 2002, 99(4):538-548.
7. Baselga J., Eur J. Cancer 2001, 37(Suppl 4):S16-S22.
8. Bates D.O., Cui T.G., Doughty J.M., Winkler M., Sugiono M., Shields J.D., Peat D., Gillatt D., Harper S.J. Cancer Res. 2002, 62(14):4123-4131.
9. Bergmann C., Strauss L., Wieckowski E., Czystowska M., Albers A., Wang Y., Zeidler R., Lang S., Whiteside T.L. Head Neck 2009, 31(3):371-380.
10. Bonner J.A., Harari P.M., Giralt J., Azarnia N., Shin D.M., Cohen R.B., Jones C.U., Sur R., Raben D., Jassem J., Ove R., Kies M.S., Baselga J., Youssoufian H., Amellal N., Rowinsky E.K., Ang K.K. N Engl J. Med. 2006, 354(6):567-578.
11. Bozec A., Formento P., Ciccolini J., Fanciullino R., Padovani L., Murraciole X., Fischel J.L., Milano G. Mol. Cancer Ther. 2005, 4(12):1962-1971.
12. Casanova M.L., Larcher F., Casanova B., Murillas R., Fernandez-Acenero M.J., Villanueva C., Martinez-Palacio J., Ullrich A., Conti C.J., Jorcano J.L. Cancer Res. 2002, 62(12):3402-3407.
13. Cerniglia G.J., Pore N., Tsai J.H., Schultz S., Mick R., Choe R., Xing X., Durduran T., Yodh A.G., Evans S.M., Koch C.J., Hahn S.M., Quon H., Sehgal C.M., Lee W.M., Maity A. PLoS One 2009, 4(8):e6539.
14. De Luca A., Carotenuto A., Rachiglio A., Gallo M., Maiello M.R., Aldinucci D., Pinto A., Normanno N. J. Cell. Physiol. 2008, 214(3):559-567.
15. Goldman C.K., Kim J., Wong W.L., King V., Brock T., Gillespie G.Y. Mol. Biol. Cell 1993, 4(1):121-133.
16. Hecht J.R., Mitchell E., Chidiac T., Scroggin C., Hagenstad C., Spigel D., Marshall J., Cohn A., McCollum D., Stella P., Deeter R., Shahin S., Amado R.G. J. Clin. Oncol. 2009, 27(5):672-680.
17. Hirata A., Ogawa S., Kometani T., Kuwano T., Naito S., Kuwano M., Ono M. Cancer Res. 2002, 62(9):2554-2560.
18. Huang S.M., Li J., Harari P.M. Mol. Cancer Ther. 2002, 1(7):507-514.
19. Huang S., Armstrong E.A., Benavente S., Chinnaiyan P., Harari P.M. Cancer Res. 2004, 64(15):5355-5362.
20. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. J. Clin. Investig. 1973, 52(11):2745-2756.
21. Jain R.K. Nat. Med. 2001, 7(9):987-989.
22. Kim H.S., Shin H.S., Kwak H.J., Cho C.H., Lee C.O., Koh G.Y. FASEB J. 2003, 17(2):318-320.
23. Kuwai T., Nakamura T., Sasaki T., Kim S.J., Fan D., Villares G.J., Zigler M., Wang H., Bar-Eli M., Kerbel R.S., Fidler I.J. Neoplasia 2008, 10(5):489-500.
24. Mriouah J., Boura C., Pinel S., Chretien A.S., Fifre A., Merlin J.L., Faivre B. Int. J. Oncol. 2010, 37(6):1555-1563.
25. Muralidharan-Chari V., Clancy J.W., Sedgwick A., D'Souza-Schorey C. J. Cell Sci. 2010, 123(Pt 10):1603-1611.
26. Perrin R.M., Konopatskaya O., Qiu Y., Harper S., Bates D.O., Churchill A.J. Diabetologia 2005, 48(11):2422-2427.
27. Perrotte P., Matsumoto T., Inoue K., Kuniyasu H., Eve B.Y., Hicklin D.J., Radinsky R., Dinney C.P. Clin. Cancer Res. 1999, 5(2):257-265.
28. Qayum N., Muschel R.J., Im J.H., Balathasan L., Koch C.J., Patel S., McKenna W.G., Bernhard E.J. Cancer Res. 2009, 69(15):6347-6354.
29. Repertinger S.K., Campagnaro E., Fuhrman J., El-Abaseri T., Yuspa S.H., Hansen L.A. J. Investig. Dermatol. 2004, 123(5):982-989.
30. Semino C.E., Kamm R.D., Lauffenburger D.A. Exp. Cell Res. 2006, 312(3):289-298.
31. Sini P., Wyder L., Schnell C., O'Reilly T., Littlewood A., Brandt R., Hynes N.E., Wood J. Clin. Cancer Res. 2005, 11(12):4521-4532.
32. Stoll S., Garner W., Elder J. J. Clin. Investig. 1997, 100(5):1271-1281.
33. Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL., 2010 PLoS One;5(7):e11469.
34. Taraboletti G., D'Ascenzo S., Borsotti P., Giavazzi R., Pavan A., Dolo V. Am. J. Pathol. 2002, 160(2):673-680.
35. Tol J., Koopman M., Cats A., Rodenburg C.J., Creemers G.J., Schrama J.G., Erdkamp F.L., Vos A.H., van Groeningen C.J., Sinnige H.A., Richel D.J., Voest E.E., Dijkstra J.R., Vink-Borger M.E., Antonini N.F., Mol L., van Krieken J.H., Dalesio O., Punt C.J. N Engl J. Med. 2009, 360(6):563-572.
36. Viloria-Petit A., Crombet T., Jothy S., Hicklin D., Bohlen P., Schlaeppi J.M., Rak J., Kerbel R.S. Cancer Res. 2001, 61(13):5090-5101.
37. Vincenzi B., Schiavon G., Silletta M., Santini D., Tonini G. Crit. Rev. Oncol. Hematol. 2008, 68(2):93-106.
38. Woolard J., Wang W.Y., Bevan H.S., Qiu Y., Morbidelli L., Pritchard-Jones R.O., Cui T.G., Sugiono M., Waine E., Perrin R., Foster R., Digby-Bell J., Shields J.D., Whittles C.E., Mushens R.E., Gillatt D.A., Ziche M., Harper S.J., Bates D.O. Cancer Res. 2004, 64(21):7822-7835.
39. Wu W., Onn A., Isobe T., Itasaka S., Langley R.R., Shitani T., Shibuya K., Komaki R., Ryan A.J., Fidler I.J., Herbst R.S., O'Reilly M.S. Mol. Cancer Ther. 2007, 6(2):471-483.
40. Zhu Z. Acta Pharmacol. Sin. 2007, 28(9):1476-1493.